
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
This summary of dermatology news coverage from the month of August 2025 highlights some of the most notable stories in this medical subfield.
Many different disease states and newly developed medications in the field of






